“eli-lilly” Archives

in
Entry Author Date Location
Bio Roundup: Biotech Billions, COVID-19 R&D, Zolgensma’s Path & More 04/03/20 National
Biohaven’s Acute Migraine Drug Bests Placebo in Prevention Study 03/30/20 National
FDA Rejects Boehringer Ingelheim, Eli Lilly Drug for Type 1 Diabetes 03/23/20 Europe
AbCellera’s Coronavirus “Neutralizing” Antibody Leads Enter Screening 03/17/20 National
Bio Roundup: COVID-19 Trials, Esperion’s Approvals, NASH News & More 02/28/20 National
Biohaven’s Migraine Pill Is the Latest CGRP Drug to Win the FDA’s OK 02/27/20 New York
Invetx Fetches $15M to Develop Biologic Drugs for Man’s Best Friend 02/24/20 Boston
Lundbeck’s Alder Bio Bet Pays Off With FDA Approval of Migraine Drug 02/23/20 National
Bio Roundup: Goodbye Belviq, LogicBio on Hold, Revolution’s IPO & More 02/14/20 National
Eli Lilly, Roche Drugs Fail to Move Needle in Genetically Driven Alzheimer’s 02/10/20 National
Bio Roundup: Mammoth Moves, Black Diamond’s Pop, Ohana’s Debut & More 01/31/20 National
Bio Roundup: Coronavirus Concerns, Sarepta’s CRL, Eye Drug OK’d & More 01/24/20 National
Bio Roundup: EQRx’s Ambitions, Nektar No Vote, New Frazier Fund & More 01/17/20 National
Cancer Drug Developer BioNTech to Buy Neon Therapeutics in $67M Deal 01/16/20 Boston
Eli Lilly Gets Skin in the Eczema Game With $1.1B Deal for Dermira 01/10/20 Indiana
Black Diamond Lines Up IPO as Lead Cancer Drug Nears Clinic 01/07/20 Boston
Merck Ramps Up KRAS Chase Through Licensing Deal With Taiho, Astex 01/06/20 New York
Allergan Wins FDA Nod for First Migraine Pill in New Class of Medicines 12/24/19 National
Eying Cancer Combos, Sanofi to Splash Out $2.5B on San Diego’s Synthorx 12/09/19 San Diego
Avidity Bio Adds $100M to Advance R&D of Muscle Disorder Drugs 11/13/19 San Diego
Pinteon Gets $17M to Tackle Tau in Alzheimer’s, Other Brain Diseases 10/31/19 Boston
Bio Roundup: Ichnos Emerges, Beyond CAR-T, BridgeBio Bails & More 10/18/19 National
Eli Lilly Drug Acquired in Armo Deal Fails Pancreatic Cancer Test 10/16/19 Indiana
FDA OKs Lilly’s Lasmiditan, First New Acute Migraine Drug in Decades 10/11/19 Indiana
At Big Lung Cancer Meeting, Lights Shine on KRAS, Drug Combos & More 09/09/19 National
With FDA’s Eye on JAK Drugs, Concert Moves One Ahead For Hair Loss 09/03/19 Boston
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More 08/23/19 National
Xcelerate at Biotech Week Boston Discount Ticket Sale Ends Friday 08/21/19 National
Elanco’s $7.6B Deal With Bayer Bolsters Pets, Farm Animals Footprint 08/20/19 Indiana
AbbVie’s Successor to Humira Wins FDA OK for Rheumatoid Arthritis 08/16/19 National
Page 1 of 20 next page »